Information:
Fel:
ID
18874
Beskrivning
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).
Nyckelord
Versioner (2)
- 2016-11-20 2016-11-20 -
- 2016-11-23 2016-11-23 -
Uppladdad den
23 november 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC-ND 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
WTZ-GIST-09-01 (Imatinib + LBH589) Medical History 2009-011417-24 DRKS00000657
WTZ-GIST-09-01 (Imatinib + LBH589) Medical History 2009-011417-24
Similar models
WTZ-GIST-09-01 (Imatinib + LBH589) Medical History 2009-011417-24
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Concomitant disease
Item
No concomitant disease
boolean
C0243087 (UMLS CUI [1])
Number
Item
No.
integer
C0449788 (UMLS CUI [1])
Disease description
Item
Description
text
C3259023 (UMLS CUI [1])
First Occurence
Item
1st occurence
text
C0700364 (UMLS CUI [1,1])
C0205435 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,2])